Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-cancer Analysis Identifies AIMP2 as a Potential Biomarker for Breast Cancer

1 Sept 2023

Abstract excerpt

Introduction: Aminoacyl tRNA synthetase complex interacting with multifunctional protein 2 (AIMP2) is a significant regulator of cell proliferation and apoptosis. Despite its abnormal expression in various tumor types, the specific functions and effects of AIMP2 on tumor immune cell infiltration, proliferation, and migration remain unclear. Materials and Methods: To assess AIMP2's role in tumor immunity, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Inflammasome and immune disorders
Share to interferon and immune responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38235352
DOI: 10.2174/0113892029255941231014142050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-cancer Analysis Identifies AIMP2 as a Potential Biomarker for Breast CancerPMID 38235352Read ↗

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read ↗

Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancerSemantic proximity Read ↗

Pan-Cancer Analysis Reveals Prognostic Potential of ANGPTL2 and Its Implications in Tumor MicroenvironmentSemantic proximity Read ↗

IGF2BP3 expression in pan-cancer: A bioinformatics-based study of its prognostic relevance and immunological roleSemantic proximity Read ↗

AIMP1 is a novel potential biomarker for LUAD and is associated with improved prognosisSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals that FBXO2 as a potential therapeutic target associated with immune infiltrationSemantic proximity Read ↗

Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-CancerSemantic proximity Read ↗

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancerSemantic proximity Read ↗

A Pan-Cancer Analysis of the Oncogenic Role of Insulin-Like Growth Factor2 mRNA -Binding Protein 2 (IGF2BP2) in Human TumorsSemantic proximity Read ↗

UBE2A as a prognostic indicator across human cancers: Insights from multi‑omics and immune landscape analysesSemantic proximity Read ↗

Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogeneSemantic proximity Read ↗

Comprehensive analysis of long non-coding RNA MAGI2-AS3 as a key immune regulator, therapeutic target and prognostic biomarker across pan-cancer with a focus on colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.